forum
ERIS Share Price Target
Eris Lifesciences Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
ERIS Share Price *
420.05 -4.75 (-1.12%)
* (quote may be delayed)
ERIS Share Price Forecast - Consensus
| No. of reports in last year | 4 |
| No. of analysts | 2 |
| Average Consensus Forecast | 684.25 |
| Consensus Potential | 34.42% |
ERIS Share Price Target - Broker Reports - 2019
Prabhudas Lilladher
29-Jul-19
Price @ Call: 400.6
Target: 459
ACCUMULATE
We expect sales at 16% CAGR in FY19-21E while management guided 30-50% more than the average growth of IPM and EBITDA to be rangebound, alluding to be around 34-37%. With Guwahati plant contribution in operating revenues at 61%, the management guided for more capacity utilisation to manufacture more products from Strides portfolio. This helps for better tax management with guidance of 8-10% in FY20E. Guwahati remains to be tax benefit zone till FY24E. With better traction of new products/brands, incremental Rx and net cash position, we expect stronger cash flows and higher return ratios. With stability of sales from the acquired portfolios and better visibility of earnings, we maintain ‘Accumulate’ and retain TP at Rs459 on PE 16x of FY21Eearnigns. We maintian ‘Accumulate’.
Prabhudas Lilladher
30-Jan-19
Price @ Call: 669.2
Target: 695
ACCUMULATE
ERIS Share Price Target - Broker Reports - 2018
Prabhudas Lilladher
6-Nov-18
Price @ Call: 652.48
Target: 704
ACCUMULATE
AnandRathi
22-Oct-18
Price @ Call: 708.4
Target: 879
BUY
Prabhudas Lilladher
28-May-18
Price @ Call: 774.82
Target: 885
ACCUMULATE
Prabhudas Lilladher
8-May-18
Price @ Call: 750.1
Target: 885
ACCUMULATE
Ventura
12-Apr-18
Price @ Call: 802.9
Target: 1060
BUY
ERIS Share Price Target - Broker Reports - 2017
Axis Direct
27-Nov-17
Price @ Call: 648.24
Target: 800
BUY
Bonanza
30-Oct-17
Price @ Call: 570
Target: 686
BUY
Axis Direct
21-Aug-17
Price @ Call: 590
Target: 730
BUY